Session Information
-
WCLC 2018
19th World Conference on Lung Cancer
Conference Program for the 19th World Conference on Lung Cancer in Toronto, Canada
Download PDF of the Abstract Book: Click Here.
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2391
September 23 Sun
Sep 23 Monday
September 24 Mon
Sep 24 Tuesday
September 25 Tue
Sep 25 Wednesday
September 26 Wed
Sep 26
-
+
MA02 - Improving Outcomes for Patients with Lung Cancer
- 10:30 - 12:00
- 9/24/2018
- Location: Room 201 BD
- Type: Mini Oral Abstract Session
- Track: Advanced NSCLC
-
+
MA02.03 - ASTRIS: A Real World Treatment Study of Osimertinib in Patients with EGFR T790M-Positive NSCLC
10:40 - 10:45 | Presenter: Yi-Long Wu | Author(s): Byoung Chul Cho, Qing Zhou, Gee-Chen Chang, Liyan Jiang, Giulio Metro, Claudio Martin, Gilberto De Castro, Johan F. Vansteenkiste, David Vicente, Alvin Milner, James R. Rigas, Yuh-Min Chen, Mariano Provencio
- Abstract
Loading...
-
+
OA02 - Novel Therapies in ROS1, HER2 and EGFR
- 10:30 - 12:00
- 9/24/2018
- Location: Room 105
- Type: Oral Abstract Session
- Track: Targeted Therapy
-
+
OA02.01 - Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion-Positive Non-Small Cell Lung Cancer (NSCLC)
10:30 - 10:40 | Presenter: Robert C. Doebele | Author(s): Myung-Ju Ahn, Salvatore Siena, Alexander Drilon, Matthew G Krebs, Chia-Chi Lin, Filippo G. De Braud, Thomas John, Daniel S.W. Tan, Takashi Seto, Rafal Dziadziuszko, Hendrick-Tobias Arkenau, Fabrice Barlesi, Christian Rolfo, Jürgen Wolf, Edna Chow-Maneval, Pratik S. Multani, Na Cui, Todd Riehl, Byoung Chul Cho
- Abstract
Loading... -
+
OA02.02 - Safety and Preliminary Clinical Activity of Ropotrectinib (TPX-0005), a ROS1/TRK/ALK Inhibitor, in Advanced ROS1 Fusion-Positive NSCLC
10:40 - 10:50 | Presenter: Jessica Jiyeong Lin | Author(s): Dong-Wan Kim, Alexander Drilon, Robert C. Doebele, Jeeyun Lee, Viola Zhu, Myung-Ju Ahn, John Lim, Shanna Stopatschinskaja, J. Jean Cui, David M Hyman, Ross Camidge, Sai-Hong Ignatius Ou, Alice T. Shaw, Byoung Chul Cho
- Abstract
Loading...
-
+
MA05 - Improving Outcomes in Locoregional NSCLC II
- 13:30 - 15:00
- 9/24/2018
- Location: Room 105
- Type: Mini Oral Abstract Session
- Track: Treatment of Locoregional Disease - NSCLC
-
+
MA05.02 - PACIFIC Subgroup Analysis: Pneumonitis in Stage III, Unresectable NSCLC Patients Treated with Durvalumab vs. Placebo After CRT
13:35 - 13:40 | Presenter: Johan F. Vansteenkiste | Author(s): Jarushka Naidoo, Corinne Faivre-Finn, Mustafa Özgüroğlu, Augusto Villegas, Davey Daniel, Shuji Murakami, Rina Hui, Ki Hyeong Lee, Byoung Chul Cho, Kaoru Kubota, Lynne Poole, Catherine Wadsworth, Phillip A. Dennis, Scott J Antonia
- Abstract
Loading...
-
+
MA08 - Clinical Trials in Brain Metastases
- 15:15 - 16:45
- 9/24/2018
- Location: Room 203 BD
- Type: Mini Oral Abstract Session
- Track: Advanced NSCLC
-
+
MA08.07 - Real World Data of Osimertinib in Patients with Central Nervous System (CNS) Metastasis in ASTRIS Korean Subset.
15:50 - 15:55 | Presenter: Jin-Hyoung Kang | Author(s): Byoung Chul Cho, Dong-Wan Kim, Keunchil Park, Jong-Seok Lee, Seung soo Yoo, Sung Yong Lee, Cheol Hyeon Kim, Seung Hun Jang, Young-Chul Kim, Hyoung-Kyu Yoon, Sang-We Kim
- Abstract
Loading...
-
+
P1.01 - Advanced NSCLC (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.01-01 - ROS1-Positive Non-Small Cell Lung Cancer: Real-World Data in Korea
16:45 - 18:00 | Presenter: Beung Chul Ahn | Author(s): Sehhoon Park, Sung Won Lim, Hye Ryun Kim, Min Hee Hong, Byoung Chul Cho, Myung-Ju Ahn
- Abstract
Loading... -
+
P1.01-21 - Safety of Durvalumab Retreatment in Advanced NSCLC Patients Who Progressed Following Initial Disease Control In ATLANTIC
16:45 - 18:00 | Presenter: Marina Chiara Garassino | Author(s): Byoung Chul Cho, Joo-Hang Kim, Julien Mazieres, Johan F. Vansteenkiste, Hervé Lena, Jesus Corral, Jhanelle Elaine Gray, John Powderly, Christos Chouaid, Paolo Bidoli, Paul Wheatley-Price, Keunchil Park, Ross Soo, Yifan Huang, Catherine Wadsworth, Phillip A. Dennis, Naiyer A Rizvi
- Abstract
Loading...
-
+
P1.13 - Targeted Therapy (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.13-36 - Randomized Phase 2 Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild-Type Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Lecia Sequist | Author(s): Jhanelle Elaine Gray, Wael A Harb, Robert C. Doebele, Manuel R; Modiano, David Michael Jackman, Maria Quintos Baggstrom, Akin Atmaca, Enriqueta Felip, Mariano Provencio, Manuel Cobo Dols, Bambang Adiwijaya, Geoffrey Kuesters, Walid Kamoun, Karen Andreas, J Marc Pipas, Sergio Santillana, Byoung Chul Cho, Keunchil Park, Frances A Shepherd
- Abstract
Loading...
-
+
P1.16 - Treatment of Early Stage/Localized Disease (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.16-06 - Expanded Efficacy and Safety Analysis of PACIFIC Based on a PD-L1 Cutpoint of 25%
16:45 - 18:00 | Presenter: Alexander Spira | Author(s): David Planchard, Byoung Chul Cho, Mustafa Özgüroğlu, Davey Daniel, Augusto Villegas, David Vicente, Rina Hui, Shuji Murakami, Luis Paz-Ares, Anne-Marie Boothman, Lynne Poole, Catherine Wadsworth, Phillip A. Dennis, Scott J Antonia
- Abstract
Loading...
-
+
PL02 - Presidential Symposium - Top 5 Abstracts
- 08:15 - 09:45
- 9/25/2018
- Location: Plenary Hall
- Type: Plenary Session
- Track: Advanced NSCLC
-
+
PL02.01 - Overall Survival with Durvalumab Versus Placebo After Chemoradiotherapy in Stage III NSCLC: Updated Results from PACIFIC
08:15 - 08:25 | Presenter: Scott J Antonia | Author(s): Augusto Villegas, Davey Daniel, David Vicente, Shuji Murakami, Rina Hui, Takayasu Kurata, Alberto A. Chiappori, Ki Hyeong Lee, Maike De Wit, Byoung Chul Cho, Maryam Bourhaba, Xavier Quantin, Takaaki Tokito, Tarek Mekhail, David Planchard, Young-Chul Kim, Chris S. Karapetis, Sandrine Hiret, Gyula Ostoros, Kaoru Kubota, Jhanelle Elaine Gray, Luis Paz-Ares, Javier De Castro Carpeño, Corinne Faivre-Finn, Martin Reck, Johan F. Vansteenkiste, David R. Spigel, Catherine Wadsworth, Maria Taboada, Phillip A. Dennis, Mustafa Özgüroğlu
- Abstract
Loading...
-
+
OA10 - Right Patient, Right Target & Right Drug - Novel Treatments and Research Partnerships
- 10:30 - 12:00
- 9/25/2018
- Location: Room 106
- Type: Oral Abstract Session
- Track: Targeted Therapy
-
+
OA10.06 - A First-in-Human Phase 1 Trial of the EGFR-cMET Bispecific Antibody JNJ-61186372 in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
11:25 - 11:35 | Presenter: Keunchil Park | Author(s): Myung-Ju Ahn, Se-Hoon Lee, Hye Ryun Kim, Min Hee Hong, Dawn Millington, Martin Curtis, Spyros Triantos, Sandra Chaplan, Nahor Haddish-Berhane, Roland Knoblauch, Zuleima Aguilar, Sylvie Laquerre, Matthew V. Lorenzi, Byoung Chul Cho
- Abstract
Loading...
-
+
P3.16 - Treatment of Early Stage/Localized Disease (Not CME Accredited Session)
- 12:00 - 13:30
- 9/26/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P3.16-02 - Phase III Study of Canakinumab (ACZ885) as Adjuvant Therapy in Patients with Surgically Resected NSCLC
12:00 - 13:30 | Presenter: Edward B Garon | Author(s): Andrea Ardizzoni, Fabrice Barlesi, Byoung Chul Cho, Pedro De Marchi, Yasushi Goto, Shun Lu, Luis Paz-Ares, David R. Spigel, Michael Thomas, Pilar Cazorla Arratia, Jason Baum, Yvonne Y Lau, Cheng Zheng, James Chih-Hsin Yang
- Abstract
Loading...